This document discusses the pathology of tuberculosis and leprosy lesions. It describes the types and morphology of granulomatous lesions caused by each disease. For tuberculosis, it covers primary and secondary pulmonary TB as well as extrapulmonary TB. It discusses non-caseating and caseating granulomas and the role of host immunity. For leprosy, it describes the clinical classifications and pathophysiology of tuberculoid and lepromatous forms. It also notes complications that can arise from delayed diagnosis or treatment of each disease.
The PPT is mainly all about Mycobacterium Tuberculosis. Agents causing the disease Tuberculosis, pathogenesis, laboratory diagnosis, treatment and prophylaxis. It was made for both BSc and MSc students.
Introduction
Disease
Important Properties
Transmission & Epidemiology
Risk factor of reactivation
Pathogenesis
Clinical Findings
Laboratory Diagnosis
Approaches to the diagnosis of latent infections
Treatment
Prevention
The PPT is mainly all about Mycobacterium Tuberculosis. Agents causing the disease Tuberculosis, pathogenesis, laboratory diagnosis, treatment and prophylaxis. It was made for both BSc and MSc students.
Introduction
Disease
Important Properties
Transmission & Epidemiology
Risk factor of reactivation
Pathogenesis
Clinical Findings
Laboratory Diagnosis
Approaches to the diagnosis of latent infections
Treatment
Prevention
Rubella, also known as German measles or three-day measles, is an infection caused by the rubella virus. This disease is often mild with half of the people not realizing that they are infected. A rash may start around two weeks after exposure and last for three days.
This is a series of lectures on microbiology, useful for both undergraduate and post graduate medical and paramedical students... This lecture covers cholera, typhoid, diarrhoea and dysentry
Do you know Mycoacterium leprae cannot e cultured in normal medium? Do you know leprosy is one of the least contagious diseases? To know more interesting facts see the slide
Rubella, also known as German measles or three-day measles, is an infection caused by the rubella virus. This disease is often mild with half of the people not realizing that they are infected. A rash may start around two weeks after exposure and last for three days.
This is a series of lectures on microbiology, useful for both undergraduate and post graduate medical and paramedical students... This lecture covers cholera, typhoid, diarrhoea and dysentry
Do you know Mycoacterium leprae cannot e cultured in normal medium? Do you know leprosy is one of the least contagious diseases? To know more interesting facts see the slide
Granulomatous diseases of the head & neckMammootty Ik
covers all the important granulomatous diseases of head and neck region with a brief and to-the-point description of pathogenesis, clinical features , differential diagnosis and management of each disorder
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
5. Primary Pulmonary Tuberculosis
Primary/Ghon Complex
Initial focus of infection a small subpleural
granuloma about 10 mm in diameter with caseous
granulomas in draining hilar lymph nodes
Fibrocalcific nodule
Primary lesion get organized, leaving a
fibrocalcific nodule, however, TB bacilli may persist
as viable organism for years
Miliary TB
In immunocomprised patient primary pulmonary
TB would leads to miliary TB
5
6. Secondary Pulmonary Tuberculosis
Reactivation of old primary infection or by
reinfection
Lesions nearly always located in the lung apices,
sometimes bilaterally, and are about 30 mm in
diameter, cavitation can occur at clinical
presentation.
Histologically
Chronic caseous granulomatous inflammation
Progression of disease
Depends on the balance between host sensitivity
and organism virulence
Most lesions, converted to fibrocalcific scars
7. Extrapulmonary or Isolated Organ Secondary Tuberculosis
Dissemination of TB outside of lungs can lead to TB of tonsils, intestine,
CNS, Kidney, bone , skin and genital organs
Miliary Tuberculosis:
May be a consequence of either primary or secondary TB when resistance
to infection is particularly poor, a "miliary" pattern of spread can occur in
which small millet seed (1-3 mm) sized granulomas develops either in lung
or in other organs
Mantoux test is frequently negative
9. Pathogenesis of Granuloma Formation
• Type IV hypersensitivity or delayed type hypersensitivity as the
reaction takes several days to develop. Unlike the other types, it is
not antibody-mediated but rather is a type of cell-mediated response.
• The term delayed is used to differentiate a secondary cellular response,
which appears 48-72 hours after antigen exposure, from an immediate
hypersensitivity response, which generally appears within 12 minutes of
an antigen challenge. These reactions are mediated by T cells and
monocytes/macrophages rather than by antibodies. They are also
termed type IV hypersensitivity reactions.
• CD4+ Th1 helper T cells recognize antigen in a complex with the MHC
class II major histocompatibility complex on the surface of antigen-
presenting cells. These can be macrophages that secrete IL-12, which
stimulates the proliferation of further CD4+ Th1 cells. CD4+ T cells
secrete IL-2 and interferon gamma, inducing the further release of other
Th1 cytokines, thus mediating the immune response. Activated CD8+ T
cells destroy target cells on contact, whereas activated macrophages
produce hydrolytic enzymes and, on presentation with certain
intracellular pathogens, transform into multinucleated giant cells.
Delayed hypersensitivity reactions are inflammatory reactions initiated
by mononuclear leukocytes.
9
10. Morphology of TB Granulomas
Active Lesions; granulomatous reaction which comprises of:
Nodular collection of epithelioid cells
With or without central caseation necrosis
Langhans type of giant cells (multiple nuclei arranged in a
horse-shoe pattern)
Circumferential collar of lymphocytes
Old Lesions;
Granulomas enclosed by rim of fibroblasts
When healed, get fibrocalcifed
12. Tuberculosis and HIV infection
In the absence of appropriate
T cell-mediated immunity
granulomatous host response
does not occur
The intracellular bacteria
persist and even proliferate
within the macrophages
Mycobacterium avium infection
in a patient with AIDS, showing
clumps of acid-fast organisms
13. Clinical Manifestations of TB
Clinical Features
Systemic manifestations are produced by TNF- alpha and IL -1 released
from activated macrophages
• Fever (low grade, remittent, appear late each afternoon and then subside)
• Night sweats
• Malaise
• Anorexia
• Cough, first mucoid, later purulent and bloody sputum
• Pleuritic chest pain
14. Role of Pathologist in Diagnosis of TB
Sputum Examination: Smears stained
with Z-N examined, under oil immersion
lens, bacilli appear as red rods
FNA – enlarged lymph node
Biopsies - Pleura, Lymph nodes, Lung and
other tissues
14
16. Leprosy
Primarily a granulomatous disease of the peripheral nerves and mucosa of upper
respiratory tract
Etiology: Causative agent: Mycobacterium leprae
In 2009 WHO classify leprosy simply based on the number of (M. leprae bacilli) in
skin lesions;
Paucibacillary leprosy: skin smear from skin lesions shows no leprae bacilli
Multibacillary leprosy: skin smear from skin lesions shows M. leprae bacilli
Clinically classified on the basis of increasing severity of symptoms:
1. Tuberculoid leprosy (host with high resistance)
2. Borderline tuberculoid leprosy
3. Borderline leprosy
4. Borderline lepromatous leprosy
5. Lepromatous leprosy (host with low resistance)
* Indeterminate when not sure
17. Pathophysiology
Lepromatous form
In affected individual with defective T cell immunity,
in contrast excessive B cell response, increase
gamma globulin
Histiocytes in deep dermis and shedding epithelium
shows large numbers of bacilli
Skeletal changes frequent; like claw-hand or flat foot
In advanced leprosy, destruction of sensory nerves
with loss of sensations and circulatory alterations
lead to slowly progressive atrophy of terminal
phalanges and degenerative arthritis
18. Pathophysiology
Tuberculoid form
In affected individual with a relatively high state of natural immunity
Disease is confined to the nerves and the skeletal changes less frequent
Neurotrophic changes may regress but may progress
19. Tuberculoid leprosy
Hypopigmented macules, some become anesthetic
due to early neural involvement
Cell mediated immunity well developed, granulomatous
inflammation, scanty bacilli
Spontaneous resolution in a few years or persists and
progress to other forms
Lepromin test: positive
Borderline Tuberculoid Leprosy
Smaller and more numerous lesions with less nerve
enlargement
May persist, revert to tuberculoid leprosy, or advance to
other forms
20. Borderline Leprosy
Many asymmetrically distributed, reddish plaques, moderately anesthetic,
with regional lymphadenopathy
May persist or regress, often progress to lepromatous type
Borderline Lepromatous Leprosy
Many skin lesions with macules (flat lesions) papules (raised bumps),
plaques, and nodules, sometimes with or without anesthesia
May persist, regress or progress to lepromatous leprosy
2/17/2019
21. Lepromatous Leprosy
Early; hypopigmented macules with no sensory loss, lesions
diffuse and symmetric, with loss of hair, eyebrows or eyelashes
and disfiguring nodularity (Lepromas) of the skin
Late; nerve involvement leads to anesthetic areas and
limb weakness, advance cases aseptic necrosis occurs
Does not regress to less severe forms
Cell mediated immunity is markedly diminished no granulomas
Sheets of foamy macrophages loaded with Z-N positive Lepra
bacilli, lymphoplasmacytic infiltrate
Lepromin test: negative
2/17/2019
22. Clinical Manifestations of Leprosy
Runny nose
Dry scalp
Eye problems
Skin lesions; hypopigmented lesions with decreased sensation, do not heal
after several weeks to months
Thickening of peripheral nerves and loss of sensation in fingers and toes
Muscle weakness
Flat nose due to destruction of nasal cartilage
Skin smears or Nerve biopsy: show acid-fast bacilli with the Ziehl-Neelsen
stain or the Fite stain
23. Complications of Leprosy
Following complications can occur when
diagnosis/treatment is either delayed or started late:
Sensory loss (usually begins in extremities), injured
body parts without awareness ; can lead to additional
infections and poor wound healing
Permanent nerve damage (usually in extremities)
Muscle weakness
Progressive disfigurement (e.g; eyebrows lost,
disfigurement of the toes, fingers, and nose)
Circulatory disturbances leads to aseptic gangrene
24. Assignment
Q1. Draw a diagram of caseous and non-caseous granulomas.
Q2. Why Montoux test is negative in miliary TB?
Q3.Why wound healing is delayed in Leprosy?
Q4. Why Lepromin test is positive in Tuberculoid and negative in
Lepromatous leprosy?
2/17/2019
The sequence of events in primary pulmonary tuberculosis, commencing with inhalation of virulent M. tuberculosis and culminating with the development of cell-mediated
immunity to the organism. A, Events occurring in the first 3 weeks after exposure. B, events thereafter. The development of resistance to the organism is accompanied by the appearance of
a positive tuberculin test. Cells and bacteria are not drawn to scale. iNOS, inducible nitric oxide synthase; MHC, major histocompatibility complex; MTB, M. tuberculosis; NRAMP1,
natural resistance-associated macrophage protein